A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...
Ozempic, a weight loss drug that has exploded in use across America, has joined a list of treatments that started with benign intentions and evolved into a reflection of the modern weight loss and ...
About 140 million Americans, more than half of the nation's adults, could be considered candidates for weight loss drugs ...
There's been pressure put on Novo Nordisk to lower the cost of Ozempic and Wegovy. In late September, company CEO Lars ...
In a large-scale inspection exercise, Swiss customs authorities discovered illegal weapons, drugs and counterfeit goods. But ...
A selection of the week's best photos from across the African continent ... of Wales and shows there's more to the common sheep pen than meets the eye. The prime minister was in Paris, while ...
Doctors Without Borders and other organisations representing people with diabetes picketed outside the offices of insulin pen ...
Bluesky smiling at Lizzo, nothing but Bluesky does she see. As countless former X users have been flocking to the alternative ...
Lizzo, the Grammy award-winning singer known for her powerful voice and body-positivity advocacy, finds herself in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback